Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Baxter
McKinsey
Express Scripts
Merck
AstraZeneca
Johnson and Johnson

Last Updated: January 28, 2020

DrugPatentWatch Database Preview

Ingenus Pharms Llc Company Profile

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for INGENUS PHARMS LLC, and what generic and branded alternatives to INGENUS PHARMS LLC drugs are available?

INGENUS PHARMS LLC has fourteen approved drugs.



Summary for Ingenus Pharms Llc
US Patents:0
Tradenames:14
Ingredients:14
NDAs:14

Drugs and US Patents for Ingenus Pharms Llc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ingenus Pharms Llc OXALIPLATIN oxaliplatin INJECTABLE;INTRAVENOUS 207562-001 Oct 16, 2018 AP RX No No   Start Trial   Start Trial
Ingenus Pharms Llc DOCETAXEL docetaxel INJECTABLE;INJECTION 207563-003 Aug 31, 2017 AP RX No No   Start Trial   Start Trial
Ingenus Pharms Llc DOCETAXEL docetaxel INJECTABLE;INJECTION 207563-001 Aug 31, 2017 AP RX No No   Start Trial   Start Trial
Ingenus Pharms Llc LEUCOVORIN CALCIUM leucovorin calcium INJECTABLE;INJECTION 210917-001 Nov 23, 2018 DISCN No No   Start Trial   Start Trial
Ingenus Pharms Llc FLUOROURACIL fluorouracil INJECTABLE;INJECTION 209271-002 Dec 11, 2019 AP RX No No   Start Trial   Start Trial
Ingenus Pharms Llc ARSENIC TRIOXIDE arsenic trioxide INJECTABLE;INJECTION 209315-001 Nov 15, 2018 AP RX No No   Start Trial   Start Trial
Ingenus Pharms Llc OXALIPLATIN oxaliplatin INJECTABLE;INTRAVENOUS 207562-002 Oct 16, 2018 AP RX No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim
McKesson
Mallinckrodt
Harvard Business School
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.